Who We Are
The PanOncology Research Foundation was established to advance cancer research and education in Puerto Rico and across the Caribbean. Founded in response to persistent gaps in access to high-quality oncology education and research opportunities, the Foundation works to strengthen the capacity of healthcare professionals, researchers, and communities to improve cancer prevention, diagnosis, treatment, and survivorship.
Our Story
The PanOncology Research Foundation began as a collaborative effort among healthcare professionals and researchers committed to expanding access to oncology education in Puerto Rico. What started as a local initiative focused on mentorship and educational exposure has evolved into a regional platform that brings together hospitals, academic institutions, and international partners. Today, the Foundation serves as a hub for multidisciplinary learning, research capacity building, and community engagement.
Mission
The PanOncology Research Foundation advances cancer education and research to strengthen cancer care in Hispanic and Caribbean communities and to develop the next generation of cancer researchers.
Vision
We envision a region where access to cancer education, research, and care is equitable, inclusive, and transformative.
Values
Integrity
Transparency, accountability, and ethical leadership.
Collaboration
Multidisciplinary and cross-regional teamwork.
Equity
Reducing disparities in cancer education and research.
Innovation
Evidence-based solutions that improve care.
Compassion
Centering patients, families, and caregivers.
Education
Lifelong learning in oncology.
Research
Scientific rigor as the foundation of progress.
Leadership
Board of Directors
Marcia Cruz-Correa, MD, PhD
PRESIDENT
Dr. Marcia Cruz-Correa is a physician-scientist and board-certified gastroenterologist internationally recognized for her leadership in gastrointestinal oncology, cancer prevention, and health equity research. She earned a Bachelor of Science degree magna cum laude and a Doctor of Medicine degree with honors from the University of Puerto Rico, and completed advanced clinical training in internal medicine and gastroenterology at Johns Hopkins Hospital. She also holds a PhD in Clinical Research and Genetic Epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Cruz-Correa is a Professor of Medicine and Biochemistry at the University of Puerto Rico Medical Sciences Campus and has held senior leadership roles in academic medicine and cancer research institutions. Her career integrates clinical care, translational research, and education focused on hereditary gastrointestinal cancers and cancer prevention.
Dr. Cruz-Correa is the Founder and Chief Executive Officer of PanOncology Trials, where she leads multidisciplinary teams conducting innovative oncology clinical trials and expanding access to research-driven cancer care in Puerto Rico. She previously served as Executive Director of the University of Puerto Rico Comprehensive Cancer Center and continues to lead its Gastrointestinal Oncology Research Program, supported by more than two decades of continuous NIH funding. Her work includes early-phase clinical trials, population-based cancer registries, and strategies to reduce disparities in cancer outcomes. She holds national leadership roles within organizations such as the American Association for Cancer Research and has served on federal advisory boards shaping cancer research policy. As President of the Board, she provides strategic vision grounded in scientific excellence, equity, and a strong commitment to improving cancer outcomes in Puerto Rico and beyond.
José A. Lozada Costas, MD
VICE PRESIDENT
Dr. José A. Lozada-Costas is a board-certified hematologist and medical oncologist with extensive clinical, academic, and leadership experience in cancer care. He earned a Bachelor of Science in Chemistry from the Massachusetts Institute of Technology and completed his medical degree at the University of Puerto Rico School of Medicine. He pursued postgraduate training in Internal Medicine at Baylor College of Medicine, followed by fellowship training in Hematology and Medical Oncology at the University of Texas MD Anderson Cancer Center. Dr. Lozada has been in private practice in Puerto Rico since 2001 and is affiliated with Hospital Auxilio Mutuo in San Juan. He currently serves as Chief of the Hematology-Oncology Section and President of the Cancer Committee at Auxilio Mutuo Hospital.
Dr. Lozada brings to the Board deep expertise in clinical oncology, multidisciplinary cancer care, and institutional leadership. His long-standing involvement in academic medicine, professional societies, and clinical research strengthens the Foundation’s connection to evidence-based practice and clinical innovation. He has served in leadership roles within national and local medical organizations, including the American College of Physicians and the Puerto Rico Association of Hematology and Medical Oncology. His experience as a principal and sub-principal investigator in oncology clinical trials supports the Foundation’s mission to advance research and education. As Vice President of the Board, he provides essential clinical insight, governance leadership, and strategic guidance to strengthen the Foundation’s impact in oncology research and education.
Pedro F. Escobar, MD, MHL
TREASURER
Dr. Pedro F. Escobar is a board-certified gynecologic oncologist and Fellow of the American College of Surgeons, internationally recognized for his contributions to cancer surgery and clinical research. He completed his residency in Obstetrics and Gynecology at Northwestern University and advanced fellowship training in Gynecologic Oncology at the Cleveland Clinic Foundation. He also holds a Master’s degree in Healthcare Leadership from Brown University, complementing his clinical expertise with health systems leadership. Dr. Escobar is widely known for his pioneering work in minimally invasive and robotic surgery for gynecologic cancers. His academic career includes extensive scholarly publications and leadership in clinical innovation.
Dr. Escobar’s role on the Board is grounded in his ability to integrate clinical excellence, research innovation, and strategic leadership. He brings deep expertise in multidisciplinary cancer care, outcomes research, and translational science. His experience leading clinical programs and mentoring future oncologists supports the Foundation’s educational mission. As Treasurer, he contributes strong analytical and leadership skills to organizational governance. His perspective ensures that the Foundation’s initiatives maintain the highest standards of scientific rigor and patient-centered care.
Annette Saldaña, PharmD
SECRETARY
Dr. Annette Saldaña is an accomplished pharmacist and healthcare executive with more than three decades of experience in pharmacy operations and clinical management. She holds a Doctor of Pharmacy degree from Nova Southeastern University and a Bachelor of Science in Pharmacy from the University of Puerto Rico Medical Sciences Campus, graduating with academic distinction. She is currently Vice President of Quality and Internal Audits at PharmPix Corp., where she oversees compliance, quality assurance, and operational excellence. Throughout her career, she has held senior leadership roles in managed care organizations, directing clinical operations, formulary management, and regulatory compliance. She is a licensed pharmacist in Puerto Rico and an active member of professional pharmacy organizations.
Dr. Saldaña’s contribution to the Board is strengthened by her expertise in healthcare systems, quality management, and patient-centered operations. Her leadership experience ensures strong oversight of clinical integrity, regulatory standards, and organizational accountability. As a cancer survivor, she brings a powerful patient perspective that informs the Foundation’s mission with empathy and lived experience. Her professional background bridges clinical knowledge and operational strategy. This combination makes her an essential voice in aligning the Foundation’s educational and research efforts with real-world healthcare impact.
José Antonio Lasalde Dominici, PhD
SUB SECRETARY
Dr. José A. Lasalde Dominicci is a distinguished Puerto Rican scientist and academic leader with extensive expertise in molecular sciences and biomedical research. He earned his doctoral degree in Biochemistry from the University of Puerto Rico and completed postdoctoral training in biophysics and molecular biology at leading research institutions, including the University of California, Davis. He currently serves as a professor and researcher at the University of Puerto Rico, with appointments at both the Río Piedras and Medical Sciences campuses. Throughout his career, he has led major research centers and held senior academic leadership roles, including Vice President for Research and Interim President of the University of Puerto Rico. His scientific work focuses on neurophysiology, ion channels, and molecular mechanisms of disease.
Dr. Lasalde brings exceptional value to the Board through his deep experience in research leadership, institutional development, and scientific innovation. He has successfully secured and managed more than $100 million in external research funding, strengthening Puerto Rico’s research infrastructure. As a mentor, he has trained hundreds of young scientists who now contribute to academia, industry, and pharmaceutical research. His extensive publication record and patented discoveries reflect a sustained commitment to scientific excellence. His perspective ensures that the Foundation’s research and education initiatives are grounded in rigorous science and long-term capacity building.
Francisco G. Bruno Gonzalez, CPA, MBA
DIRECTOR COMMUNITY OUTREACH
Francisco G. Bruno is a senior financial executive, entrepreneur, and Certified Public Accountant with more than 30 years of experience in complex and highly regulated business environments. He holds a Bachelor of Science degree from Boston College and a Master of Business Administration in Finance and Corporate Strategy from the University of Michigan. In 2018, he co-founded PanOncology Trials, which has grown to become the largest and leading oncology clinical trials network in Puerto Rico. He currently serves as Contracts and Finance Director and Co-Founder of PanOncology Trials, overseeing business development, contract negotiation, and financial strategy. His career includes senior leadership roles in multinational organizations spanning healthcare, telecommunications, private equity, and real estate development.
Mr. Bruno brings to the Board deep expertise in financial governance, organizational growth, and clinical research operations. He has successfully led finance, accounting, and operational functions for large-scale clinical research centers and multinational enterprises across the Americas. His experience structuring and financing research facilities, managing audits, and overseeing regulatory compliance strengthens the Foundation’s operational sustainability. As an entrepreneur, he has founded and scaled multiple organizations, contributing a strategic and execution-focused perspective. His leadership is essential to ensuring the Foundation’s financial integrity, long-term viability, and ability to advance oncology research and education.
Carmen V. Muñoz, BSBA
PATIENT ADVOCATE
Carmen V. Muñoz is a business leader and advisor with a career spanning technology, economic development, and nonprofit governance. She is the founder of Puerto Rico Talent Network, an organization dedicated to connecting professionals and institutions committed to Puerto Rico’s long-term growth. Her professional background includes leadership roles in workforce development, international collaboration, and mission-driven enterprises. She has worked extensively with organizations focused on innovation, talent engagement, and community impact. Her experience reflects a strong commitment to strengthening organizational capacity and strategic partnerships.
Ms. Muñoz brings to the Board a unique blend of strategic insight, community leadership, and governance experience. She has served in advisory and board roles with multiple nonprofit organizations in Puerto Rico and the United States, supporting strategic planning and impact evaluation. As an early-stage breast cancer survivor, she contributes valuable lived experience that reinforces the Foundation’s patient-centered mission. Her work connecting talent, institutions, and purpose aligns closely with the Foundation’s goals of collaboration and sustainability. She plays a critical role in advancing innovation, equity, and long-term impact in oncology research and education.
Staff
